Design, Development and Characterization of Nifedipine Microspheres by Chalamalasetty, Arun Kumar et al.
Chalamalasetty et al                                                                                             Journal of Drug Delivery & Therapeutics. 2019; 9(3):138-146 
ISSN: 2250-1177                                                                                  [138]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.05.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Design, Development and Characterization of Nifedipine Microspheres 
Arun Kumar Chalamalasetty1, Narender Boggula2, Nirosha Bolledla2, Vasudha Bakshi2, Himabindu 
Peddapalli *2 
1 Department of Pharmaceutics, Jangaon Institute of Pharmaceutical Sciences, Yeshwanthpur, Jangaon, Telangana, INDIA-506 167 
2 Department of Pharmaceutics, School of Pharmacy, Anurag Group of Institutions, Venkatapur, Ghatkesar, Telangana, INDIA-500 088 
 
ABSTRACT 
Back ground: Nifedipine is a calcium channel blocker and is used in treatment of angina of angina pectoris and hypertension. Nifedipine  
readily and almost completely absorbed from GIT, but undergoes first pass metabolism, resulting in low oral bioavailability is about 50%. 
Aim: The aim of the present study was to prepare and evaluate the microspheres of nifedipine with a goal of improving the bioavailability and 
giving a prolonged release of drug.  
Method: Emulsification (o/w) solvent evaporation method was employed in the preparation of nifedipine microparticles using ethyl cellulose 
and combination of ethyl cellulose and hydroxypropyl methylcellulose as the polymers.  
Results: FT-IR spectra of physical mixture showed no significant shifting of the peaks therefore it reveals that the drug is compatible w ith the 
polymer used. The percentage yield obtained in all the formulations was good and in the range of 59.25-94.44%. Among all the formulations, 
formulation with combination of ethyl cellulose and hydroxypropyl methylcellulose polymers M9 showed high amount of drug release i.e. 
(91.23%) in 12hrs. Drug release from microspheres with small mean particle size was faster than those with large mesh particle size and 
followed Higuchi model of kinetics. 
Conclusion: The obtained results could be used as essence to develop microspheres, which bypasses first-pass metabolism and results in the 
improvement of bioavailability. Hence, the present study has been a satisfactory attempt to formulate microspheres of nifedipine, with a view of 
improving its oral bioavailability and giving a prolonged release of drug.  
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INTRODUCTION 
Microencapsulation is one of the newly developed 
techniques. Microencapsulation for oral use has been 
employed to sustain the drug release, and to reduce or 
eliminate gastrointestinal tract irritation. In addition, 
multiparticulate delivery systems spread out more uniformly 
in the gastrointestinal tract. This results in more 
reproducible drug absorption and reduces local irritation 
when compared to single-unit dosage forms such as no 
disintegrating, polymeric matrix tablets. Unwanted intestinal 
retention of the polymeric material, which may occur with 
matrix tablets on chronic dosing, can also be avoided. 
Microencapsulation is used to modify and retard drug 
release. Due to its small particle size, are widely distributed 
throughout the gastrointestinal tract which improves drug 
absorption and reduces side effects due to localized build-up 
of irritating drugs against the gastrointestinal mucosa1. 
Microencapsulation is a process of incorporating drugs into 
small size multi particulate units. As a process it is a means of 
applying relatively thin coatings to small particles of solids 
or droplets of liquids. Microencapsulation developed for use 
in medicine consists of solid or liquid core material 
containing one or more drugs enclosed in coating material2. 
The core may also be referred as nucleus and the coating as 
wall or sheet. In the present study microencapsulation was 
selected as a method to design sustained release dosage 
forms because it is a rapidly expanding technology. In this 
method relatively thin coatings are applied to small particles 
of solids or droplets of liquids and dispersions. 
Microencapsulation also used in converting liquids to solids, 
altering colloidal and surface properties, providing 
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environmental protection and in controlling the release 
characteristics or availability of coated materials. 
Nifedipine is a calcium channel blocker available in yellow, 
crystalline powder, thermostable and non-hygroscopic in 
nature. It is insoluble in water, freely soluble in acetone and 
sparingly soluble in ethanol3,4. The bioavailability of 
nifedipine is 50% and it binds with plasma to about 96%. Its 
half-life is 2-3hrs and effective concentration is about 
15ng/ml. Nifedipine readily and almost completely absorbed 
from GIT, but undergoes first pass metabolism. The volume 
of distribution after oral administration was found to be 
1.32L/kg5. Nifedipine is used in treatment and prophylaxis of 
angina of angina pectoris, Reynaud’s syndrome and 
hypertension. Therefore, preparation of a sustained release 
formulation may be desirable. 
MATERIALS AND METHODS 
Materials 
Nifedipine was a gift sample from Medreich Ltd., Bengaluru, 
Karnataka, India. Hydroxypropyl methylcellulose E5 and 
ethyl cellulose were gift samples from Dr. Reddy’s 
Laboratories, Hyderabad, Telangana, India. Dichloromethane 
AR and acetone were procured from Merck Ltd., Mumbai, 
India. PVP was purchased from Fine chemicals, Chandigarh, 
India. Disodium hydrogen Phosphate was purchased from SD 
Fine Chem Ltd., Mumbai, India. 
Methods 
Pre-formulation studies 
Organoleptic properties 
The organoleptic character of the drug like color, odor and 
appearance play an important role in the identification of the 
sample, and hence they should be recorded in a descriptive 
terminology. 
Solubility studies 
It is important to know about solubility characteristics of a 
drug in aqueous systems, since they must possess some 
limited aqueous solubility to elicit a therapeutic response. 
Solubility was carried out in water, 0.1N HCl, 0.1N NaOH, 6.8 
pH phosphate buffer, 7.4 pH phosphate buffer. 
Determination of melting point 
Melting point of the drug was determined by capillary tube 
method. Take a small amount of the drug in a capillary tube 
closed at one end and was placed in Thieles melting point 
apparatus and the temperature at which the drug melts were 
noted. Average of triplicate readings was taken. 
Determination of absorption maxima values (λmax) 
Standard stock solution of drug (100μg/ml) was prepared in 
7.4 pH phosphate buffer. For the selection of analytical 
wavelength, solution of nifedipine of concentration 30μg/ml 
was prepared by appropriate dilution of standard stock 
solution with phosphate buffer pH 7.4 and scanned in the 
spectrum range from 200 to 400nm. From this overlain 
spectrum of the drug, the wavelength with maximum 
absorbance was chosen for further analysis. 
Construction of standard calibration curve of nifedipine: 
Preparation of standard calibration curve of nifedipine 
in 7.4 pH phosphate buffer 
Procedure: 
Preparation of standard solution 
1st Stock: 1000µg/ml solution of nifedipine was prepared by 
dissolving 100 mg of nifedipine in 10ml methanol and the 
volume was made up to 100ml with 7.4 pH phosphate buffer. 
2nd Stock: Pipette 10ml of above solution into another 
100ml of volumetric flask and the volume was made up to 
mark with the 7.4 pH phosphate buffer. (i.e.: 100µg/ml in 7.4 
pH buffer). 
The above second stock solution was serially diluted with 7.4 
pH phosphate buffer to get the final concentrations of 10, 20, 
30, 40, 50 and 60µg/ml. The absorbance of each 
concentration was measured 254nm using UV-Visible 
spectrophotometer and graph was plotted against the 
concentration and absorbance6.  
Drug and excipients compatibility study 
To investigate any possible interactions between the drug 
and excipients used, the FT-IR spectra of pure nifedipine and 
its physical mixture with ethyl cellulose and hydroxylpropyl 
methylcellulose were carried out using Bomem FT-IR MB-II 
spectrophotometer. The samples were prepared as KBr 
(potassium bromide) disks compressed under a pressure of 
10 Ton/nm2. The wave number selected ranged between 400 
and 4800cm-1.  
Preparation of nifedipine microspheres  
     
Emulsification (o/w) solvent evaporation method was 
employed in the preparation of nifedipine microparticles 
using ethyl cellulose and combination of ethylcellulose and 
hydroxylpropylmethylcellulose as the polymers. Polymer 
was dissolved in 10ml of dichloromethane. To this 45mg of 
drug was added and mixed thoroughly. The above organic 
phase was added drop wise to 100ml of 1% PVA solution 
under magnetic stirrer at 800 rpm by keeping at 40 0C and 
stirring is continued until total evaporation of 
dichloromethane7,8. Then the solution was filtered and 
product was dried. Different formulations were prepared by 
taking different drug to polymer ratios 1:0.5, 1:1, 1:1.5, 1:2, 
1:2.5, 1:3, 1:3.5 and 1:4 and 1:1, 1:2, 1:3 and 1:4 of 
ethylcellulose and combination of equal ratios of 
ethylcellulose and hydroxylpropylmethylcellulose 
respectively. The prepared particles were evaluated for 
particle size, encapsulation efficiency, drug-polymer 
interaction by FT-IR and in-vitro drug release. 
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 Figure 1: Formulation of nifedipine microspheres 
 
Table 1: Formulation composition of nifedipine microspheres 
Formulation 
code 
Drug(
mg) 
HPMC E5 
(mg) 
Ethyl 
cellulose 
N50 (mg) 
DCM 
(ml) 
Acetone 
(ml) 
PVA 
(%) 
Drug : 
Polymer 
M1 45 22.5 _ 10 _ 1 1:0.5 
M2 45 45 _ 10 _ 1 1:1 
M3 45 67.5 -- 10 _ 1 1:1.5 
M4 45 90 _ 10 _ 1 1:2 
M5 45 112.5 _ 10 _ 1 1:2.5 
M6 45 135 _ 10 _ 1 1:3 
M7 45 157.5 _ 10 _ 1 1:3.5 
M8 45 180 _ 10 _ 1 1:4 
M9 45 22.5 22.5 5 5 1 1:1 
M10 45 45 45 5 5 1 1:2 
M11 45 67.5 67.5 5 5 1 1:3 
M12 45 90 90 5 5 1 1:4 
 
Characterization of microspheres9-12 
Percentage yield 
Microspheres dried at room temperature were weighed and 
the yield of microspheres was calculated using the 
formula11,12. 
                 
                                  
           (  )                             
     
Encapsulation Efficiency  
To determine encapsulation efficiency, 100mg accurately 
weighted microspheres were washed and dissolved in 
100ml with phosphate buffer pH 7.4 solution. The 
microspheres were kept to soak for overnight. After 12hrs 
the solution was filtered through membrane filter. The 
volume was made up to 100ml with phosphate buffer pH 7.4 
and analyzed for drug content spectrophotometrically at 254 
nm13. 
                     
 
                                     
                                        
     
Determination of mean particle size of microspheres 
Particle size distribution of microspheres was carried out by 
optical microscopy. A minute quantity of dried microspheres 
was suspended in glycerin and the particle size of 100 
microspheres was determined in each batch and the mean 
particle size was calculated. The average particle size was 
determined by using the Edmondson's equation9.  
Edmondson's equation D = 
   
 
 
Scanning electron microscopy (SEM) 
For the external morphology studies, air dried particles were 
visualized using scanning electron microscopy (FEI-Quanta 
200F) operating at 15 kv. The samples were mounted on a 
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metal slab with double adhesive tape and coated with 
platinum under vacuum9-11. 
In-vitro release studies 
In-vitro release profile for microspheres performed using 
USP type 1 dissolution apparatus11,12. Sample equivalent to 
45mg of nifedipine was added to 900ml phosphate buffer of 
pH 7.4 at 37±0.5 0C and stirred at 100rpm. Aliquot of 5ml 
was withdrawn at time intervals of 0.5, 1, 1.5, 2, 2.5, 3, 4, 5, 6, 
7, 8, 10 and 12 hrs. The withdrawn volume was replenished 
with the same volume of dissolution medium in order to 
keep the total volume constant. The absorbance of the 
samples was measured at 254nm using phosphate buffer of 
pH 7.4 as blank. Results of in-vitro drug release studies 
obtained from absorbance data were tabulated and shown 
graphically as Cumulative % drug released Vs Time. 
Kinetics analysis of dissolution data 
There are a number of kinetic models, which described the 
overall release of drug from the dosage forms14. Data 
obtained from the in-vitro release was fit into different 
equations and kinetic models to explain the release kinetics 
of nifedipine from these microspheres. The kinetic models 
used were a zero-order equation, first order equation, 
Higuchi and Korsmeyer-Peppas model. Higuchi model is the 
most widely used model to describe drug release from 
pharmaceutical matrices system15. 
The Peppas model is widely used, when the release 
mechanism is not well known and when more than one type 
of release is involved. To find out the mechanism of drug 
release, drug release data were fitted in Korsmeyer-Peppas 
model16. To study the diffusional release mechanism, data 
obtained from in-vitro drug release studies were plotted 
against log cumulative percentage drug release versus log 
time. The value of n was estimated by linear regression of 
log Mt/M∞ versus log t. 
  
   
  Ktn 
Where,  
  
   
 is fraction of drug released at time t. 
t is release time, 
K is Kinetic constant (incorporating structural and geometric 
characteristics of preparation), 
n is Diffusional exponent indicative of the mechanism of the 
drug release. 
RESULTS AND DISCUSSION 
Preformulation studies 
The solubility of drug in water, 0.1N HCl, 0.1N NaOH, 6.8 pH 
phosphate buffer, 7.4 pH phosphate buffer were determined 
and results are shown in Table 2. The organoleptic 
properties of nifedipine were performed and physical 
appearance was good, elegant and results were compiles 
with pharmacopoeia values of drug characteristics. The 
melting point of drug was determined and was found to be 
172-174 0C. 
Table 2: Solubility studies of nifedipine 
S. No. Medium  Solubility 
1 Water 29mg/ml 
2 0.1N HCl 15mg/ml 
3 0.1N NaOH 18mg/ml 
4 6.8 pH phosphate buffer 11mg/ml 
5 7.4 pH phosphate buffer 10mg/ml 
Determination of absorption maximum values 
An UV-Spectrophotometric method was used for 
determination of absorption maxima. The λmax of nifedipine 
(30μg/ml) in 7.4 pH phosphate buffer was scanned in UV-
Visible Spectrophotometer in the wavelength range of 200-
400nm and found to have maximum absorbance at 254nm. 
 
Figure 2: UV absorption spectrum of nifedipine in 
phosphate buffer pH 7.4 
Preparation of standard calibration graph of nifedipine 
in pH 7.4 phosphate buffer 
The solutions of nifedipine were prepared in phosphate 
buffer pH 7.4 (10- 60µg/ml) and the absorbance of resulting 
solutions was measured at 254nm using UV 
spectrophotometer. The calibration curve showed a good 
linearity with correlation coefficient of R2 0.999. 
 
Figure 3: Standard graph of nifedipine in buffer pH 7.4 
Drug and excipients compatibility studies 
Fourier Transform Infra-Red Spectroscopy (FT-IR) 
FT-IR spectroscopy was used to ensure that no chemical 
interactions between the drugs and polymer had occurred. 
The presence of interaction is detected by the disappearance 
of important functional group of the drug. The FT-IR spectra 
of nifedipine and polymer mixture showed several 
characteristic peaks. The FT-IR spectrum of pure nifedipine 
showed the characteristic peaks at wave numbers of 3320 
cm-1 due to >N–H stretching (>N–H of pyridine), at 1680 cm-1 
due (N=O)2 asymmetric stretching (Aryl-NO)2, at 1220 cm-1 
is due to (N=O)2 symmetric stretching (Aryl-NO2) and at 
1520 cm-1 due to asymmetric carboxylate anion confirming 
the drug structure. The spectrum of nifedipine and polymer 
mixture also showed the characteristic peaks for nifedipine 
indicating no interaction between the drug and polymers 
used. This indicates that there is no chemical interaction 
between drug and polymer mixture, that the molecular 
structure of nifedipine remained completely intact. 
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Figure 4: FT-IR spectrum of pure drug (nifedipine) 
 
 
Figure 5: FT-IR spectrum of mixture of drug and polymers 
Percentage yield 
Percentage yield of microspheres is calculated and the 
percentage yield for all the ratios of microspheres were 
found to be in the range of 59.25-93.33% and 60.55-94.44% 
for ethylcellulose and combination of ethylcellulose and 
hydroxypropyl methylcellulose respectively in which batch 
MP12 shows highest percentage yield 94.44%. The loss of 
material during preparation of microspheres may be due to 
process parameters as well as filtration of microspheres. 
Percentage yield of all batches is shown in Table 3. 
Encapsulation efficiency    
     
The encapsulation efficiency of all the formulations was 
found to be in the range of 65.87-94.75% and 70.15-95.23% 
for formulations composed of ethyl cellulose and 
combination of ethylcellulose and hydroxypropyl 
methylcellulose respectively in which batch MP12 shows 
highest entrapment efficiency 95.23% and batch MP1 shows 
lowest entrapment efficiency 65.87%. From the results it 
was seen that as the polymer concentration increased, 
viscosity of the dispersed phase increased, the encapsulation 
efficiency increased. This may be because of the availability 
of high amount of polymer to encapsulate the drug. The 
values of percentage encapsulation efficiency were shown in 
Table 3. 
Particle size determination 
The mean particle size of microspheres containing ethyl 
cellulose was found to be 133.5µm, 157.4µm, 189.3µm, 
200.5µm, 215.6µm, 223.5µm, 234.7µm, 246.1µm for MP1 to 
MP8 batches and mean particle size of microspheres 
containing ethylcellulose and hydroxypropyl 
methylcellulose combination was found to be 210.1µm, 
235.4µm, 243.9µm, 250.6µm for MP9 to MP12 batches 
respectively. In which MP12 shows highest particle size. As 
the polymer ratio increased the size of the particles 
increased. This may be because of viscosity of the polymer 
solution which increases as the polymer concentration 
increases and availability of high amount of polymer to coat 
the drug particles and deposition of many polymer layers. 
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Table 3: Particle size, % encapsulation efficiency and percentage yield of microspheres 
Formulation Particle size 
(µm) 
Encapsulation 
efficiency (%) 
Percentage yield 
(%) 
MP1 133.5±1.25 65.87±1.56 59.25 
MP2 157.4±1.34 67.13±1.84 63.88 
MP3 189.3±1.28 68.24±0.97 68.88 
MP4 200.5±.87 68.55±2.34 74.07 
MP5 215.6±2.34 74.44±1.39 78.73 
MP6 223.5±1.84 79.04±1.52 83.33 
MP7 234.7±1.57 86.17±1.13 91.35 
MP8 246.1±0.96 94.75±1.40 93.33 
MP9 210.1±1.23 70.15±2.15 60.55 
MP10 235.4±1.45 75.87±0.80 74.07 
MP11 243.9±1.72 88.88±1.62 86.11 
MP12 250.6±1.34 95.23±1.55 94.44 
 
 
Figure 6: Mean particle size of formulations (MP1-MP4) 
 
Figure 7: Mean particle size of formulations (MP5-MP8) 
 
Figure 8: Mean particle size of formulation (MP9-MP12) 
Scanning electron microscopy 
The microspheres prepared by solvent evaporation method 
showed a good spherical shape, with smooth surface and the 
particles are distributed uniformly without any lumps as 
shown in the Figure 9. 
 
Figure 9: SEM analysis of prepared microspheres 
In-vitro release studies 
The in-vitro release profile of nifedipine microspheres were 
conducted in pH 7.4 phosphate buffer for 12hrs. The in-vitro 
drug release data for each of the formulations is shown in 
Figures 10-12. The cumulative percentage drug release after 
12hrs was found to be 88.29%, 84.30%, 80.80%, 75.73%, 
70.23%, 66.19%, 61.42%, 58.29% for formulations MP1 to 
MP8 and 91.17%, 86.85%, 82.12%, 78.47% for formulations 
MP9 to MP12 respectively. The release profile was gradually 
decreased by increasing the polymer ratio.  
From the released data observed that increase in the 
polymer content delays the drug release due to increased 
particle size and decreased surface area available for drug 
release. Among all the formulations prepared with ethyl 
cellulose polymer MP1 showed high amount of drug release 
i.e. (88.25%) and among all the formulations prepared with 
combination of ethyl cellulose and hydroxylpropyl 
methylcellulose polymers MP9 showed high amount of drug 
release i.e. (91.23%) in 12hrs.  
From all the twelve formulations improved drug release was 
observed with combination of polymers i.e. (91.23%) as it 
contained both hydrophilic polymer with hydrophobic one 
compared to formulation prepared with ethyl cellulose i.e. 
(88.25%) as it contained hydrophobic polymer. This might 
be due to addition of hydrophilic nature of the polymer 
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which has more affinity for water results in increased 
thermodynamic activity of the drug in the microspheres. 
 At lower polymer concentration, a burst release was seen, 
which was more in case of ethyl cellulose and HPMC 
containing formulations as compared to single ethyl 
cellulose formulations, which may due to surface drug 
present on the microspheres. 
 
 
Figure 10: % drug release of nifedipine microspheres (MP1-MP4) 
 
Figure 11: % drug release of nifedipine microspheres (MP5-MP8) 
 
 
Figure 12: % drug release of nifedipine microspheres (MP9-MP12) 
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Release kinetic plots for best formulation (MP9) 
microspheres containing nifedipine 
The kinetic data of various models revealed that 
formulations MP1, MP2, MP4, MP6, MP8, MP9, MP11 followed 
zero order release kinetics with diffusion controlled 
mechanism and MP3, MP5, MP7, MP10 followed first order 
release kinetics. The kinetic data of optimized formulation 
MP9 was shown in the Figures 13-16. 
 
Figure 13: Plots of Log (T) Vs Log (%) release for 
formulation MP9 
 
Figure 14: Plots of Time (T) Vs Log (%) Remain for 
formulation MP9 
 
 
Figure 15: Plots of square root (T) Vs Cumulative (%) 
release (Q) for formulation MP9 
 
 
Figure 16: Plots of Log (T) Vs Log (%) release (Q) for 
formulation MP9 
CONCLUSION 
The present study had been a satisfactory attempt to 
formulate microspheres of nifedipine, an orally administered 
calcium channel blocker used in the treatment of angina 
pectoris drug with a view of improving its oral bioavailability 
and giving a prolonged release of microspheres with 
polymers such as ethyl cellulose and hydroxypropyl 
methylcellulose were successfully prepared by 
emulsification solvent evaporation method. 
Based on the results obtained it can be concluded that MP9 
was found to be the ideal formulation considering its size 
and release profile. Hence microspheres were better choice 
of drug delivery system than many other types of drug 
delivery system and plays vital role in place in novel drug 
delivery, particularly in diseased cell sorting, diagnostics, 
gene and genetic materials, safe, targeted, specific drug 
delivery. 
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